Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Final beam laid for new BioEscalator/Novo Nordisk Building, due to open Summer 2018

Image courtesy of Tony Brett

Last week a topping out ceremony was held at the BioEscalator/ Novo Nordisk Building at Old Road Campus to celebrate its final beams being laid. The building will house the Oxford BioEscalator and Novo Nordisk Research Centre Oxford (NNRCO) when it opens in Summer 2018. 

An incredible 15,000 tons of steel work, 3,000 bolts, 5,700 tons of concrete, 423 parking spaces, and 183,000 man hours with no reportable accidents have gone into creating the building and its 2,800mof labspace and offices. 

Elen Wade-Martins, Business Manager for the BioEscalator, and Jim Johnson, Head of the NNRCO, tightened the final bolts on the building and celebrated their vision for the future of the space. 

Novo Nordisk/ Bioescalator topping out

Elen Wade-Martins and Jim Johnson at the Topping Out Ceremony. Photo by David Fleming. 

Elen Wade-Martins commented: 'The BioEscalator will help early stage bioscience companies to overcome obstacles to become sustainable businesses, and enable more of the exciting medical innovation in our labs at the University to make it to the clinic.' 

Jim Johnson expects: 'The new building will be a hub of innovation and collaboration where fundamental biological discoveries are made and translated towards therapeutics for the ultimate benefit of the patients we are dedicated to helping.' 

 

 

Similar stories

AIMday in Women's Health - registration for academics now open

Events Innovation

Are you an academic interested in finding out how your knowledge can be used to solve industry challenges? Would you like to widen your network? Meet potential collaborators / future employees? Gain insights into relevant funding schemes? If you answer YES to any of the above, now is the time to register for the AIMday in Women's Health.

UK and EU regulators conclude benefits of vaccination continue to outweigh the risks

Coronavirus COVID-19 General

Today, the medical regulators in the UK and Europe have announced their conclusions from their reviews of very rare cases of unusual blood clots in people who have received the Oxford-AstraZeneca coronavirus vaccine.

Link between COVID-19 infection and subsequent mental health and neurological conditions found

Coronavirus COVID-19 General Research

One in three COVID-19 survivors received a neurological or psychiatric diagnosis within six months of infection with the SARS-CoV-2 virus, an observational study of more than 230,000 patient health records published in The Lancet Psychiatry journal estimates. The study looked at 14 neurological and mental health disorders.

New national study of long-term impacts of debilitating lung damage from COVID-19

Coronavirus COVID-19 General Research

A new national study will investigate the long-term effects of lung inflammation and scarring from COVID-19. The study, launched with £2 million of funding from UK Research and Innovation (UKRI), aims to develop treatment strategies and prevent disability.

Opportunities for final goodbyes must be prioritised in COVID-19 pandemic

Coronavirus COVID-19 General Research

Bereaved relatives described the ongoing pain of being absent at the end of a loved-one's life. Many had not seen their relative for weeks or months due to the pandemic. Opportunities must be prioritised for essential connections between families at end-of-life care.